Clinical trial
Interventional, Open-Label, Single Cohort, Canadian Study to Describe the Relationship Between Cognitive Symptoms and Work Productivity in Working Adults Treated With Vortioxetine for Major Depressive Disorder (MDD)
NCT02332954 is registered in ClinicalTrials.gov with Lundbeck Canada Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional, Open-Label, Single Cohort, Canadian Study to Describe the Relationship Between Cognitive Symptoms and Work Productivity in Working Adults Treated With Vortioxetine for Major Depressive Disorder (MDD)
- Lead sponsor
- Lundbeck Canada Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- July 6, 2017
- Enrollment
- 226 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.